> Take me to the Healthcare Professional Section  > Take me to the Patient Section

THIS PAGE IS INTENDED FOR THE UK PUBLIC

GLAUCOMA
CONJUNCTIVITIS

For further information on
Glaucoma please click this link

For further information on
Conjunctivitis please click this link

non-infectious inflammatory conditions affecting the anterior segment of the eye

 For further information, please click this link

Further information can be found below:

These links will take you to the electronic Medicines Compendium (eMC) website.

Eysano Patient Information leaflet: View

Eydelto Patient Information leaflet: View

Eylamdo Patient Information leaflet: View

Eykappo Patient Information leaflet: View

Eyreida Patient Information leaflet: View

Eythalm Patient Information leaflet: View

Eysano 2.5 mg/ml Eye Drops, Solution Summary of Product Characteristics: View SmPC

Eysano 5 mg/ml Eye Drops, Solution Summary of Product Characteristics: View SmPC

Eydelto 20mg/ml Eye Drops, Solution Summary of Product Characteristics: View SmPC

Eylamdo 20mg/ml Dorzolamide + 5mg/ml Timolol Eye Drops, Solution Summary of Product Characteristics: View SmPC

Eykappo 5 mg/ml eye drops solution Summary of Product Characteristics: View SmPC

Eyreida 0.3mg/ml eye drops solution Summary of Product Characteristics: View SmPC

Eythalm 1mg/ml eye drops solution Summary of Product Characteristics: View SmPC

For further information please call: 01730 231148,
email: info@aspirepharma.co.uk or visit www.aspirepharma.co.uk

Reporting of Side Effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the product’s package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.
Revision reference – Ey Range_3_20/06/2018